Literature DB >> 5771533

Leukemia in polycythemia vera. Relationship to splenic myeloid metaplasia and therapeutic radiation dose.

J H Lawrence, H S Winchell, W G Donald.   

Abstract

Entities:  

Mesh:

Year:  1969        PMID: 5771533     DOI: 10.7326/0003-4819-70-4-763

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  8 in total

1.  Present status of 32P-therapy in management of polycythemia vera.

Authors:  G Meuret
Journal:  Klin Wochenschr       Date:  1975-06-15

2.  Synergism between hepatocellular injury and shunting in portosystemic encephalopathy (PSE): case report of acute brittle TIPS-induced PSE.

Authors:  Gil Weitzman; Neil J Schamberg; Gerond Lake-Bakaar
Journal:  Dig Dis Sci       Date:  2007-07-20       Impact factor: 3.199

3.  Acute transformation of essential thrombocythaemia: report of two cases.

Authors:  A M O'Hea; W Erber; N T O'Connor; C Bunch
Journal:  J Clin Pathol       Date:  1986-12       Impact factor: 3.411

4.  32P-therapy in polycythemia vera.

Authors:  G Meuret; G Hoffmann; R Gmelin
Journal:  Klin Wochenschr       Date:  1975-06-01

5.  Myelosuppression in polycythemia vera: chemotherapy or radiotherapy?

Authors:  Y Najean; C Dresch
Journal:  Blut       Date:  1982-01

6.  Management of small elevated pigmented choroidal lesions.

Authors:  D H Char; M J Hogan
Journal:  Br J Ophthalmol       Date:  1977-01       Impact factor: 4.638

7.  Use and risks of phosphorus-32 in the treatment of polycythaemia vera.

Authors:  Claude Parmentier
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-09-03       Impact factor: 9.236

8.  Treatment of polycythaemia vera by radiophosphorus or busulphan: a randomized trial. "Leukemia and Hematosarcoma" Cooperative Group, European Organization for Research on Treatment of Cancer (E.O.R.T.C.).

Authors: 
Journal:  Br J Cancer       Date:  1981-07       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.